Oragenics
OGEN
7 hedge funds and large institutions have $33M invested in Oragenics in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
26% more capital invested
Capital invested by funds: $26.1M → $33M (+$6.88M)
17% more funds holding
Funds holding: 6 → 7 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
+$8.21M |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$55.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$8K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$3K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$2K |
OGEN Hedge Fund Activity: Q3 2013 in Review
7 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2013, worth a combined $33M — up 26% from $26.1M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new OGEN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Third Security, adding an estimated $8.21M. The largest seller was Deutsche Bank, cutting an estimated $15K.
- 7 institutional investors held Oragenics (OGEN) as of Q3 2013, up from 6 in Q2 2013.
- Funds reported $33M of Oragenics stock for Q3 2013, up 26% quarter-over-quarter.
- 1 fund opened new Oragenics positions in Q3 2013 and 0 closed out, a net change of +1 holder.
- The largest Oragenics buyer in Q3 2013 was Third Security, an estimated $8.21M added.
- The largest Oragenics seller in Q3 2013 was Deutsche Bank, an estimated $15K sold.
Based on aggregated 13F filings for Q3 2013.